Mastitis is a common complication of human lactation. We examined milk spec
imens from eight women with clinical mastitis to determine their content of
anti-inflammatory components. Antioxidant activity (spontaneous cytochrome
c reducing activity), selected pro-inflammatory cytokines (IL-6, IL-1 beta
), selected endogenous cytokine control molecules (sIL-6R, sIL-1RII, and sT
NFRI), lactoferrin, Na+:K+ ratios, and milk bioactivities that cause sheddi
ng of sIL-1RII from human polymorphonuclear leukocytes (PMN), suppress PMN
aggregation, and suppress PMN adherence responses were not increased compar
ed to normal milks. Neither the bioactivities that deplete PAIN intracellul
ar Ca2+ stores nor those that block Ca2+ influx into fMLP-stimulated PMN we
re significantly increased in mastitis milks. In contrast, levels of TNF al
pha, sTNFRII, and IL-1RA and bioactivities that cause shedding of sTNFRI fr
om human PMN were significantly increased compared to normal milks. Mastiti
s milk has the same anti-inflammatory components and characteristics of nor
mal milk, with elevations in selected components/activities that may help p
rotect the nursing infant from developing clinical illness due to feeding o
n mastitis milk. (C) 2001 Academic Press.